Advances in Drug Delivery Strategies for Microbial Healthcare Products

作者: Jose Manuel Ageitos , Marcos Garcia-Fuentes

DOI: 10.1007/978-3-030-01881-8_1

关键词:

摘要: Biomacromolecules produced by microorganisms have been employed in healthcare ever since ancient times as part of fermented products or natural remedies, but from the discovery penicillin 1928 Alexander Fleming, it is impossible to conceive medicine without microbial products. In addition antibiotics, produce secondary metabolites currently anti-inflammatory, immunosuppressant, and antitumoral drugs, among others. As with any other well-established undesirable side effects may occur these compounds due excessive systemic drug concentrations, their pharmacological activity can be lost development resistance target cells. Besides, many drugs intrinsic physicochemical properties that limit application such low aqueous solubility, bioavailability, acute toxicity, fast pre-systemic degradation.

参考文章(163)
David A Lee, T. C. Lee, S. Kitada, A. E. Cortes, Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation. Investigative Ophthalmology & Visual Science. ,vol. 31, pp. 2136- 2144 ,(1990)
Roberto Carlos Bravo González, Jörg Huwyler, Isabelle Walter, Richard Mountfield, Beate Bittner, Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension. International Journal of Pharmaceutics. ,vol. 245, pp. 143- 151 ,(2002) , 10.1016/S0378-5173(02)00339-3
Ryo Kojima, Takatsune Yoshida, Hiroaki Tasaki, Hiroyuki Umejima, Masashi Maeda, Yasuyuki Higashi, Shunsuke Watanabe, Naoto Oku, Release mechanisms of tacrolimus-loaded PLGA and PLA microspheres and immunosuppressive effects of the microspheres in a rat heart transplantation model International Journal of Pharmaceutics. ,vol. 492, pp. 20- 27 ,(2015) , 10.1016/J.IJPHARM.2015.07.004
Erik De Clercq, Antonín Holý, Acyclic nucleoside phosphonates: a key class of antiviral drugs Nature Reviews Drug Discovery. ,vol. 4, pp. 928- 940 ,(2005) , 10.1038/NRD1877
T Takeuchi, K Maeda, H Umezawa, Y Okami, New antibiotics, bleomycin A and B. The Journal of Antibiotics. ,vol. 19, pp. 200- 209 ,(1966)
Jun Zhou, Daxin Zhou, improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers Drug Design Development and Therapy. ,vol. 9, pp. 5269- 5275 ,(2015) , 10.2147/DDDT.S90016
Jiaojiao Xu, Beihua Xu, Dan Shou, Xiaojing Xia, Ying Hu, Preparation and Evaluation of Vancomycin-Loaded N-trimethyl Chitosan Nanoparticles Polymers. ,vol. 7, pp. 1850- 1870 ,(2015) , 10.3390/POLYM7091488
Y. Danyuo, S. Dozie-Nwachukwu, J.D. Obayemi, C.J. Ani, O.S. Odusanya, Y. Oni, N. Anuku, K. Malatesta, W.O. Soboyejo, Swelling of poly(N-isopropylacrylamide) P(NIPA)-based hydrogels with bacterial-synthesized prodigiosin for localized cancer drug delivery. Materials Science and Engineering: C. ,vol. 59, pp. 19- 29 ,(2016) , 10.1016/J.MSEC.2015.09.090
Negin Malakooti, Cameron Alexander, Carmen Alvarez-Lorenzo, Imprinted Contact Lenses for Sustained Release of Polymyxin B and Related Antimicrobial Peptides Journal of Pharmaceutical Sciences. ,vol. 104, pp. 3386- 3394 ,(2015) , 10.1002/JPS.24537
Claudio Nastruzzi, Capretto, Mazzitelli, Brognara, Lampronti, Carugo, Hill, Zhang, Gambari, Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia International Journal of Nanomedicine. ,vol. 7, pp. 307- 324 ,(2012) , 10.2147/IJN.S25657